Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis

Publication Date

2025

Content Type

Article

PubMed ID:

40790607

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS